Products of Novatemed Innoceuticals, Inc. are tested for ensuring reliability and efficacy both at the in-vitro level and in-vivo level by internationally accredited testing institutions located in France and the U.S.A. These products are released to global market only after being approved as compliant with international standards and superior than competitors' products.
Novatemed Innoceuticals, Inc. is integrated with the world’s prominent accredited research and technology institutes, and established a multi-faceted research collaborations with them.
Novatemed Innoceuticals, Inc. holds various international patents and trademarks.
Products of Novatemed Innoceuticals, Inc. are being sold globally; especially in the U.S.A, France, U.K., Germany, Belgium and Turkey.